Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

OMNIPAQUE 240

GE HEALTHCARE CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of OMNIPAQUE 240 in Canada?

A shortage of OMNIPAQUE 240 518MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated November 18, 2026), but it has not started yet.

When will OMNIPAQUE 240 be available again?

The manufacturer's estimated resolution date is February 10, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file2 products
Expected resolution~3 months remaining (estimate)
Affected strength518MG
Report last updated2026-11-18
Checked by MedShort2026-11-19

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

OMNIPAQUE 350

GE HEALTHCARE CANADA INC

755MG · DIN 02172755

Different strengthSame dosage formSame routeNo current shortage

OMNIPAQUE 300

GE HEALTHCARE CANADA INC

647MG · DIN 02172747

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-02-10

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02172739

Strength

518MG

Dosage Form

SOLUTION

Route

RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL

Active Ingredient

IOHEXOL

Tier

Unrated

Last Updated

2026-11-18

Reason for Shortage

Other (Please describe in comments)

Other Products from GE HEALTHCARE CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.